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Virulence of extraintestinal pathogenic Escherichia coli strains in Caenorhabditis elegans  
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mice 
 
Comparison of the virulence of extraintestinal pathogenic Escherichia coli in Caenorhabditis 
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Abstract 
 
Extraintestinal pathogenic Escherichia coli (ExPEC) strains cause diseases by invading normally 
sterile niches within host body, e.g., urinary tract, blood and cerebrospinal fluid. Infections due to 
ExPEC strains, in particular urinary tract infections, are causing considerable morbidity and important 
health-care costs. The goal of our study is to evaluate whether the nematode Caenorhabditis elegans 
can be used as a model to study phenotypic and genetic virulence determinants of ExPEC strains. For 
this purpose, we used a collection of 31 E. coli strains isolated during acute extra-intestinal infections or 
from the feces of healthy individuals. For all strains, the phylogeny, the presence of ExPEC virulence 
factors, the resistance to biologically relevant stressors (i.e., bile, human serum and lysozyme), the 
motility, the growth rate, the virulence in C. elegans and in murine septicaemia model has been 
established. The results show that there is a strong link between virulence in C. elegans and certain 
phenotypic and genetic virulence predictors of ExPEC strains determinable in vitro. Furthermore, there 
is an excellent correlation between virulence of different ExPEC strains in C. elegans and in the murine 
models. The virulence of ExPEC strains, which is expected to be a continuous trait resulting from the 
interaction of variable number and types of virulence factors in different strains, is even better revealed 
and more easily analysed in C. elegans than in the murine model. Therefore, our results show that C. 
elegans can be used as a model to study virulence determinants of ExPEC strains 
 
  
 
Introduction 
 
Most Escherichia coli strains are harmless commensals of the gastrointestinal tract of humans and 
warm-blooded animals, however, some strains are able to cause intestinal and extraintestinal diseases 
((16)). E. coli strains that cause gastrointestinal diseases are rarely found in the fecal flora of the healthy 
hosts and are, in general, not capable of causing disease outside of the intestinal tract. Extraintestinal 
pathogenic E. coli (ExPEC) strains are normally found in host intestinal tract, sometimes in very high 
frequency, without causing enteric disease. ExPEC strains can cause diseases by invading normally 
sterile niches within host body, e.g., urinary tract, blood and cerebrospinal fluid. ExPEC strains are 
traditionally classified as pyelonephritogenic, uropathogenic, sepsis-associated and neonatal meningitis-
associated pathotypes, on the basis of the syndrome they have been associated with. ExPEC strains can 
cause disease at all host ages, but the incidence of serious infections increases with age, due to the 
anatomical and physiological changes with aging and to the impairment of immune functions. 
Commensal strains can also cause extraintestinal infections, but only when aggravating factors are 
present, e.g., host immunodeficiency, obstruction of biliary tract, presence of foreign body like urinary 
catheter. Among different extraintestinal infections due to E. coli strains, urinary tract infections (UTI) 
are, by their frequency and potential severity, causing considerable morbidity and important health-care 
costs (24).  
ExPEC strains are distinct from commensal and intraintestinal pathogenic E. coli strains by their 
specific virulence factors. ExPEC virulence factors include adhesins (e.g., P and I fimbriae), iron-
acquisition systems (e.g. aerobactin), host defense-avoidance systems (e.g., capsule, 
lipopolysaccharide), and toxins (e.g., hemolysin, cytotoxic necrotizing factor 1) (15), (14). Most of 
ExPEC virulence factors are encoded by genes that are clustered on pathogenicity islands (PAI), i.e., 
big genomic or plasmidic regions, up to 200 kb in length (11).  PAIs seem to be acquired via horizontal 
gene transfer, as suggested by their G + C content that is usually different from that of the rest of the 
genome. They are often associated with tRNA loci, which may represent target sites for the integration 
in the chromosome. As PAIs are flanked by direct repeats or insertion sequence elements, they have 
tendency to delete with high frequencies and can undergo duplications and amplifications. 
Consequently, PAIs are present in different combination, with varying overlap among different PAIs 
with respect to virulence factors content, and with different frequency among E. coli strains responsible 
for extraintestinal infections. However, in spite of the formidable promiscuity of horizontal gene 
transfer in bacteria, ExPEC PAIs are found predominantly in strains belonging to E. coli phylogenetic 
 group B2 and, to lesser extent, to group D(21). Their presence is extremely rare in phylogenetic groups 
A and B1 to which belong vast majority of commensal and intraintestinal pathogenic E. coli strains. 
Such link between ExPEC virulence factors and phylogeny could correspond to the necessity of having 
virulence determinants into the right genetic background for the emergence of a virulent clone.  
The goal of our study is to evaluate whether Caenorhabditis elegans can be used as a model to study 
different phenotypic and genetic virulence determinants of ExPEC strains. C. elegans is a simple and 
economic invertebrate animal model that is increasingly used as model host for the study of 
mechanisms of microbial pathogenesis in recent years (20). C. elegans is a free-living nematode, 
normally found in the soil and rotting vegetation worldwide. Use of hermaphrodite, self-fertilizing C. 
elegans enables maintenance of homozygous mutant stocks. C. elegans requires very cheap and simple 
growth conditions, i.e. they grow on a layer of bacteria in an agar plate. When worms eat bacteria, they 
are crushed by the grinder situated in the pharynx and then pass into the intestine. However, a small 
fraction of bacteria pass through the grinder intact and enter the intestine. Once in the gut, some 
pathogenic bacteria are capable of proliferation and killing the nematode by an infectious process, while 
other bacteria kill through the use of toxins. A rapidly growing number of human, plant and animal 
microbial pathogens, both gram-negative and gram-positive have been shown to injure and kill C. 
elegans (20). In many cases, microbial genes known to be important for virulence in mammalian 
models were shown to be required for virulence in nematodes. Furthermore, C. elegans as a model 
system for pathogenesis provides opportunity to simultaneously explore the molecular genetic 
determinants of both pathogen virulence and host defense because it possesses a complex inducible 
innate immune system, involving multiple signaling pathways, as well as many antimicrobial proteins 
and peptides.  
C. elegans has been used to evaluate virulence of E. coli intraintestinal pathogenic strains (2), but the 
virulence of ExPEC strains have never been tested in this model organism. For this study, we used a 
collection of E. coli natural isolates composed of commensal and ExPEC strains. Our results indicated 
that C. elegans can successfully be used as a model organism for ExPEC pathogenesis. We think that 
the use of such a simple and economic animal model can greatly facilitate the study of the contribution 
of different virulence factors, their combinations and the strain genetic background to the in vivo 
virulence of ExPEC strains. The obtained results can then, in a targeted way, be validated in costly 
mammal model hosts. 
 
MATERIALS AND METHODS 
 
Bacterial strains. E. coli strains isolated from extraintestinal infections (21 strains) and from feces 
 of healthy humans (10 strains) used in this study, as well as their relevant genotypes, are listed in Table 
S1. E. coli 536 High Pathogenicity Island (HPI) and rfe (synonym for wecA) mutant strains were 
constructed using the PCR-based method as described by Datsenko and Wanner [(6); For more details 
see ONLINE SUPPLEMENTARY MATERIAL]. E. coli 536 PAI III mutant strain was kindly provided 
by U. Dobrindt and J. Hacker (Institut für Molekulare Infektionsbiologie, Universität Würzburg, 
Germany). In addition, E.coli laboratory OP50 (standard food for C. elegans) and MG1655 strains were 
also used. Saturated overnight cultures of E. coli strains were obtained by growing cells in Luria–
Bertani (LB) medium at 37 °C with shaking, supplemented with appropriate antibiotics when needed 
[chloramphenicol (30µg/ml), ampicilin (100µg/ml)]. 
 
Measurement of the growth rate of the E. coli strains in nematode growth medium (NGM). 
Saturated overnight cultures were diluted in MgSO4 10-2 mol/L, and about 107 cells were added to liquid 
NGM (13) in 96 wells plaque.  Growth was followed by measuring the optical density at 600 nm, every 
5 minutes during 24h, using IEMS spectrophotometer (Perkin Elmer) at 25°C with shaking. The 
generation time (min) was calculated as time necessary for a two-fold increase of optical density during 
growth phase fitting an exponential curve. Each assay was repeated in, at least, three independent 
experiments.  
 
Measurement of the motility of the E. coli strains in NGM. Saturated overnight cultures were 
diluted in MgSO4 10-2 mol/L, and about 30 cells were added to 20 ml of melted NGM soft agar (4.5 g/l 
agarose) in 9-cm-diameter plates. Solidified plates were incubated for 36 h at 25°C, then the surface of, 
at least, 10 colonies was measured with Elix software (Microvision Instruments) and the mean surface 
calculated. For each strain, in each assay, the motility was normalized using values obtained for E. coli 
MG1655 strain. Each assay was repeated in, at least, three independent experiments. 
 
Measurement of human serum, bovine bile and lysozyme/lactoferrin resistance of the E. coli 
strains. Saturated overnight cultures were diluted in MgSO4 10-2 mol/L and the sensitivity of cells to 
human serum, bovine bile and lysozyme/lactoferrin was measured as follows: (i) About 105 cells were 
added to 1ml of 75% human serum (Institut Jacques Boy S.A.) diluted in LB. After 1h of incubation at 
37°C without shaking, the number of live bacteria was estimated by plating on LB agar. Serum 
resistance was estimated as follows: log [CFU/ml (t1h) / CFU/ml (t0)]. (ii) About 103 cells were added to 
5ml of 20% bovine bile (Merck) diluted in LB. After 17h of incubation at 37°C with shaking, the 
number of live bacteria was estimated by plating on LB agar. Bovine bile resistance was estimated as 
follows: log [CFU/ml (t17h)/ CFU/ml (t0)]. (iii) About 103 cells were added to 200µl of 1% bacto-
 peptone supplemented with 0.05mg/ml of egg lysozyme (Sigma) and 1 mg/ml of lactoferrine from 
bovine colostrums (Sigma) (lactoferrin was used in order to enhance sensitivity to lysozyme (8)). 
Lysozyme is involved in the bacteriolytic activity of human serum (26). After 17h of incubation at 25°C 
with shaking, the number of live bacteria was estimated by plating on LB agar. Lysozyme/lactoferrin 
resistance was estimated as follows: log [CFU/ml (t17h)/ CFU/ml (t0)]. Each assay was repeated in, at 
least, three independent experiments. 
 
C. elegans - killing assay. The C. elegans fer-15 conditional sterile mutant (kindly provided by J. J. 
Ewbank, CIML, Marseille, France) was maintained at 15°C to have fertile worms, and at 25°C to have 
sterile population after synchronization, as previously described (13). Plates for killing assay were 
prepared as follows. 100 µl of the saturated overnight bacterial cultures were spread on 9-cm-diameter 
plates containing NGM agar. The NGM plates were incubated at 37°C for 24h, and then allowed to 
equilibrate to room temperature for 30 to 60 min before being seeded with worms. In each assay, at 
least 60 L4-stage synchronized nematodes were added per plate, and each assay was carried out at least 
tree times. The plates were incubated at 25°C and live and dead worms were scored every 24 h. During 
the first six to ten days, live worms were transferred to a new NGM plate with fresh bacterial lawn 
every 48h. A worm was considered dead when it failed to respond to plate tapping or gentle touch with 
a platinum wire. Worms that died as a result of getting stuck to the wall of the plate were excluded from 
the analysis.  
 
Partie pour Erick: Murine septicaemia model. The virulence of E. coli strains that have not 
previously been assayed in mouse septicaemia model was performed as described previously (ref). 
Pathogen-free female of the outbred white Swiss mice lineage (Rj: Swiss-IOPS Orl) (6 to 8 weeks old, 
25 to 30 g) were purchased from the Centre d'Elevage R. Janvier (Le Genest, Saint Isle, France). The E. 
coli strains were grown in Trypticase soy broth medium (pH 7.3, osmolarity = 271 mOsm/l) (AES 
Laboratories) with shaking at 37°C to a density of 109 bacteria per ml. The bacterial count was 
determined by measuring the optical density at 530 nm. A 2-ml sample of the culture was then 
centrifuged at 2,500 × g for 10 min, washed twice with Ringer solution, and resuspended in Ringer 
solution. These suspensions were used to inoculate the mice subcutaneously in the abdomen or 
intraperitoneally. Ten mice were inoculated with each strain, and number of dead mice during 7 days 
was noted. 
 
Statistical analysis. A factorial analysis of correspondence (FAC) was used to describe associations 
among different sets of data. FAC uses a covariance matrix based on 2 distances (10). The computation 
 determines a plane defined by two principal axes of the analysis; the first axis F1, accounts for most of 
the variance, and the second axis F2, orthogonal to F1, accounts for the largest part of the variance that 
is not accounted by F1.  
FAC was conducted with SPAD.N software (Cisia, Saint Mandé, France) from a two- way table 
which had 31 rows, one for each E. coli strain and 34 columns corresponding to the 34 variables: 4  E. 
coli phylogenetic groups (A, B1, B2 and D), 17 virulence factors (named as in supplementary table S1), 
5 serotypes (O2, O6, O18, O81, other O-groups), pathogen / commensal origin, motility, serum 
resistance, bile resistance, lysozyme/lactoferrin resistance, growth rate,  fast / slow  worm killer and 
mouse lethality (Figure 2). For each column, each strain was coded as a binary code: present =1, absent 
= 0. 
Influence of different factors on the hazard ratio (ratio between mortality rates) was tested using a 
Cox proportional hazard (CPH) model (5), (27). The hazard ratio in survival analysis is a summary of 
the difference between two survival curves, representing the change in the risk of death compared to 
control, according to an explanatory variable (Phenotype/Genotype), over the period of follow-up. The 
model uses a computable algorithm to summarise the relative risks of death across all time intervals into 
a single figure (). 
Numerical values for the (multiplicative) effect of each covariate can be calculated as exp() after 
estimation of  . For figures 1, 3 and 4, 95% confidence intervals were calculated based on the estimated 
standard deviation of the z-distributed , using a robust jackknife estimate of the variance and grouping 
observations with respect to bacterial strains, where necessary. In the text, hypothesis testing based on 
P-values (predictors of pathogenicity and effect of deletion mutations) followed the Bonferroni-Holm 
procedure (12) for repeated significance testing for the pooled CPH anaylses. 
The proportional hazards regression model we use here assumes that the relative risk of death 
between the different groups is constant at each interval of time. This has been tested for using a chi-
square test statistic for the pearson moment-correlation between the scaled Schoenfeld residuals and the 
log-transformed time (27). In those cases where significant non-proportionality was found, a graphical 
representation showed that the effect of non-proportionality did not alter the overall conclusions. All 
survival analyses were performed using R (http://www.r-project.org/) version 2.2.1. 
 
RESULTS 
 
Characterization of E. coli natural isolates. The pathogenicity of E. coli natural isolates in C. 
elegans host model was evaluated by measuring the survival of worms fed on pure cultures of these  
strains. The results show that different strains have very different virulence (Fig. 1; for raw survival 
 curves see Fig S1). In order to identify variables that could explain such strain-dependent pathogenicity, 
E. coli isolates were genotypically and phenotypically characterized. For genetic characterization, the 
phylogenetic group, the presence of PAIs and of ExPEC virulence factors were determined (Table S1). 
The phenotypes under investigation were: the growth rate in NGM at 25°C, motility, resistance to 
bovine bile, human serum and lysozyme/lactoferrin, as well as the pathogenicity of the strains in the 
murine septicaemia model (Table 1). All phenotypic data were binarized for further analysis (Table 1).  
 
Predictors of pathogenicity of E. coli natural isolates in the C. elegans. In order to identify 
associations between different variables and pathogenic potential of E. coli natural isolates in the C. 
elegans, factorial analysis of correspondence (FAC) was conducted using all data available for the 
studied strains (Fig. 2). The projections of the variables on the plane F1/F2 that accounts for 44.76 % of 
the total variance distinguish two main groups of variables by the positive and negative values of the 
first factor (F1). The first group (positive values of F1 and F2) encompasses the mouse lethality; the 
pathogenic origin of the strains; the “fast worm killer” character; the phylogenetic group B2; O2, O6 
and O18 serotypes; the resistances to serum, bile and lysozyme/lactoferrin; the motility; fast growth 
rate, and the most of the virulence factors. The second group (negative values of F1 and positive values 
of F2) encompasses the commensal origin of the strains; the absence of mouse lethality; the “slow 
worm killer” character; the phylogenetic groups A and B1; and O81 serotype. A third group of variables 
that is distinguished by the negative values of F2, encompasses the phylogenetic group D, aerobactin, 
pap GII genes and presence of PAI I. 
Therefore, FAC retrieved two distinct groups of E. coli natural isolates: (i) strains isolated during 
acute extra-intestinal infections that belong to B2 phylogenetic group, and that are highly virulent for 
humans and mouse, and (ii) strains isolated from the feces of healthy individuals that belong to A and 
B1 phylogenetic groups, and that are less virulent for humans and mouse. The character “fast worm 
killer” is unambiguously projected in the first group whereas the character “slow worm killer” is 
projected in the second one. 
In order to confirm or reject hypotheses concerning connections between pathogenicity in C. 
elegans, in vitro phenotypes, presence of PAIs and virulence in murine septicaemia model indicated by 
FAC, we performed a Cox proportional hazard (CPH) analysis. Using CPH analysis, it is possible to 
take into account the entirety of survival data (including censored observations), instead of relying only 
on single values, e.g. mean survival. With regard to presence of PAI II, PAI III, and HPI, the CPH 
analysis reveals that PAI II (p=6.2 × 10-3), PAI III (p=2.2 × 10-2), are significantly associated with 
higher C. elegans mortality, while HPI is not (p=2.2 × 10-1) (Figure 3.a). Concerning in vitro 
 phenotypes, CPH analysis indicates that resistance to lysozyme/lactoferrin (p=1.1 × 10-5) and to human 
serum (p=3.4 × 10-2) are significantly correlated with an increase in mortality of C. elegans, while 
resistance to bovine bile, the growth rate in NGM and motility are not (Figure 3.b). Finally, CPH 
analysis indicates that pathogenicity of different E. coli strains in the C. elegans and in the mouse model 
is significantly correlated (p=2.1 × 10-4) (Figure 3.c).  
 
Pathogenicity of 536 ExPEC strain mutants in C. elegans. Three E. coli 536 mutants were used to 
experimentally verify connections between different variables and pathogenicity in C. elegans as 
identified by CPH analysis. The first two mutant strains have PAI III and HPI deleted, respectively. PAI 
III was chosen because CPH analysis showed that it is significantly associated with higher C. elegans 
mortality, while HPI was chosen as a negative control. The third mutant, which has the rfe gene deleted, 
was used to test the link between resistance to lysozyme/lactoferrin and to human serum, and 
pathogenicity in C. elegans. rfe codes for the UDP-GlcNAc:undecaprenylphosphate GlcNAc-1-
phosphate transferase involved in the biosynthesis of the Enterobacterial Common Antigen (ECA) and 
of the lipopolysaccharide (LPS) O-antigen (reviewed in (23)). We have chosen to inactivate this gene 
because it was previously reported that the inactivation of rfe gene decreases the resistance to bile of 
Salmonella enterica (22), as well as the virulence of S. enterica during oral and intraperitoneal infection 
in mice (22). The inactivation of rfe in 536 strain attenuates its resistance to lysozyme/lactoferrin, 
human serum and bovine bile (Table 1). A CPH analysis, with regard to presence of PAI III, HPI, rfe 
and C. elegans mortality, reveals that inactivation of PAI III (p=2.6 × 10-11) and rfe gene (p=2.6 × 10-17) 
significantly attenuates pathogenicity in C. elegans, while inactivation of HPI does not (Figure 4).  
 
DISCUSSION 
 
The goal of our study is to evaluate whether C. elegans can be used as a model to study phenotypic 
and genetic virulence determinants of ExPEC strains. For this purpose, we used the collection of 31 E. 
coli strains isolated during acute extra-intestinal infections or from the feces of healthy individuals 
(Table S1). For all strains, we established the phylogeny, the presence of ExPEC virulence factors, in 
vitro resistance to biologically relevant stressors (i.e., bile, human serum and lyzosyme), the motility, 
the growth rate, the virulence in C. elegans and in murine septicaemia model (Table 1). Subsequently, 
in order to identify associations between all these different variables, we conducted factorial analysis of 
correspondence (FAC). FAC indicated that there is link between presence of various ExPEC virulence 
factors, B2 phylogenetic group and virulence in murine septicaemia model (Fig 2), which was 
 previously observed (21). However, the association of these traits with the motility, the resistance to 
human serum, bile and lysozyme/lactoferrin, as well as the virulence in C. elegans is observed for the 
first time (Fig 2).  
As motility has been described as an important feature of UTI causing strains (28), it is not surprising 
that most of the studied ExPEC strains are motile (Table 1). The immobility of the most of strains 
isolated from the feces (Table 1) could be an adaptation to the commensal style of life, as E. coli 
flagellin can induce a pro-inflammatory response in the mammalian enterocytes in vivo (3). Therefore, 
the E. coli strains that do not present flagellin on the cell surface could be favoured in the populations of 
intestinal bacteria. The association of ExPEC strains with the resistance to the human serum, to 
lysozyme/lactoferrin and to bile, with the virulence in C. elegans and in murine septicaemia model 
reflects the importance of the capacity of ExPEC cells to protect membrane integrity against host 
defences. Thus, many of the associations between different characters suggested by FAC are 
corroborated by what is already known from the scientific literature concerning E. coli species. The 
question remains which of those of those characters identified by FAC as linked with ExPEC strains are 
specifically involved in virulence in the C. elegans model. We tried to answer to this question using 
Cox proportional hazard (CPH) analysis.  
 
Identification of ExPEC phenotypic and genetic determinants relevant for the virulence in C. 
elegans model. C. elegans appears to be killed by ExPEC strains in an infectious process as previously 
observed for other bacterial strains (20) (data not shown). This process consists of an accumulation of 
the pathogen inside the intestine of the worm causing distension of the gut and death of the animal. In 
our attempt to untangle this intrinsically multifactorial phenomenon of virulence, we decided to 
examine possibly relevant phenotypes on one hand, and known genetic virulence determinant on the 
other hand.  
However, not all of the inspected phenotypic traits showed correlation with increased mortality (Fig 
3): It seems that motility has no importance in the C. elegans model, this is corroborated by the 
observation that there is also no correlation between virulence in C. elegans and the capacity of E. coli 
strains to form biofilm, while there is a good correlation between motility and biofilm formation (data 
not shown). It should be noted that growth rate does not predict virulence in C. elegans, implying that 
worm mortality is not a simple indicator of overall bacterial fitness. 
The capacity of bacteria to protect membrane integrity is important in C. elegans because the latter 
produces many molecules with antibacterial activity, e.g., lysozymes, lectins, lipases, aspartic and 
cysteine proteases, saposin-like proteins and several antibacterial peptides (reviewed in (20)). Among 
genes known to be required for the virulence of different bacterial species in C. elegans, many code for 
 membrane constituents, e.g., Pseudomonas aeruginosa aefA (25) gene, S. enterica rfaL (1), ompR gene 
(18) and wze homologue gene of Serratia marcescens (17). Consequently, resistance to human serum 
and to lysozyme/lactoferrin of E. coli strains play a role in the capacity to kill nematodes (Fig 3). The 
non-correlation between worm-mortality and bile resistance suggests that the worm digestive tract 
mimics conditions of extraintestinal infections rather than those within a mammal intestine. 
. We have experimentally verified connections between bacterial resistance and pathogenicity in C. 
elegans by inactivating rfe in ExPEC strains 536 (Fig 4, Table 1) and F11 as well as the commensal 
IAI1 strain (data not shown). rfe is required for LPS biosynthesis (23) and its deletion causes the 
“rough” phenotype, which has been shown to be associated with attenuation of resistance to human 
serum (14). All three rfe mutants have significantly diminished capacity to kill C. elegans, and heavily 
impaired resistance to human serum, bile and lysozyme/lactoferrin.  
The PAIs under investigation differ both in size and in content, and include unique, PAI-specific 
functions as well as redundant ones. This was reflected by our finding that while PAI II and PAI III are 
clearly associated with higher C. elegans mortality, HPI is not or far less so. Our experiments do 
confirm these correlations; we deleted PAI III from 536 strain and observed that the mutant has indeed 
reduced virulence in C. elegans, while the deletion of HPI has no effect. Among known genes carried 
by PAI III, two categories could play a role in virulence in C. elegans, those coding for adhesins, and 
those coding for siderophores, as it was observed for the pilA gene encoding a putative pilus structural 
protein in Burkholderia pseudomallei (9) and the ferrisiderophore receptor (y3343) of S. marcescens 
(17). The deletion of PAI III in 536 strain attenuated resistance to lysozyme (to a lesser extent than that 
of rfe mutant), which probably contributes to the attenuation of the virulence of PAI III mutant in C. 
elegans (Table 1). The lack of the effect of HPI deletion on virulence in C. elegans may be explained by 
redundancy between functions encoded by HPI and PAI III, i.e., both PAIs carry genes involved in the 
iron uptake,(4) ,(7). 
 
Concluding remarks. We have established a strong link between virulence in the C. elegans and 
certain phenotypic and genetic predictors of ExPEC strains’ pathogenicity determinable in vitro. 
Excellent correlation between virulence of different ExPEC strains in the C. elegans and in the murine 
septicaemia model further confirms that C. elegans can be used as a model to study virulence 
determinants of ExPEC strains (Figure 3.c). Furthermore, the virulence of ExPEC strains, which is 
expected to be a continuous trait resulting from the interaction of variable number and types of 
virulence factors in different strains, is better revealed and more easily analysed in C. elegans than in 
the frequently used murine septicaemia model (Fig 1, Table 1). Therefore, C. elegans can be used to 
identify functions of many genes with unknown functions present on ExPEC PAIs, as well as new 
 virulence factors elsewhere on the chromosomes of ExPEC strains. The obtained results can then, in a 
targeted way, be validated in mammal model hosts. 
 
Strain
Worm 
Mean 
Lifespan 
(days)
Binarized 
Résistance 
to Serum ‡  
Binarized 
Resistance 
to 
Lysozyme ‡ 
Binarized 
Resistance 
to Bile 
bovine ‡
Binarized 
Motility ‡  
 Binarized 
generation 
time ‡
Mice 
killed†
Binarized 
Mice 
killing 
phenotype
MG1655 8.56 -5.00 (0.00) 0 0.28 (0.38) 0 -0.01 (1.87) 0 1.00 (0.00) 1 123.7 (21.8) 0 0 MNK
OP50 11.76 -5.00 (0.00) 0 -0.99 (0.32) 0 -3.00 (0.00) 0 0.04 (0.01) 0 116.8 (30.5) 1 0 MNK
F11 5.94 -0.19 (0.32) 1 3.57 (0.65) 1 6.21 (0.02) 1 1.97 (0.75) 1 93.2 (1.5) 1 9 MK
F63 5.72 -0.27 (0.31) 1 4.07 (0.37) 1 3.79 (0.29) 1 1.07 (0.33) 1 118.8 (5.6) 0 9 MK
RS218 6.06 -0.26 (0.30) 1 4.01 (0.27) 1 3.93 (1.11) 1 1.31 (0.52) 1 117.5 (2.0) 0 10 MK
ED1A 8.32 -0.94 (0.23) 1 0.14 (0.39) 0 -0.50 (1.54) 0 0.04 (0.00) 0 130.0 (8.8) 0 0 MNK
CFT073 7.78 -0.10 (0.05) 1 4.01 (0.50) 1 -3.00 (0.00) 0 3.34 (0.60) 1 128.4 (5.1) 0 9 MK
J96 6.13 -1.28 (0.06) 0 4.06 (0.36) 1 5.19 (0.67) 1 4.08 (0.36) 1 137.7 (3.4) 0 0 MNK
IAI1 5.68 0.01 (0.04) 1 0.37 (0.48) 0 6.60 (0.15) 1 0.04 (0.00) 0 104.5 (1.1) 1 0 MNK
IAI2 9.13 -1.79 (1.60) 0 0.71 (0.43) 0 -0.86 (2.14) 0 0.04 (0.00) 0 179.3 (38.9) 0 0 MNK
IAI4 8.68 -4.00 (1.00) 0 1.17 (0.38) 0 1.13 (2.08) 1 0.04 (0.01) 0 116.5 (11.4) 1 0 MNK
IAI12 7.60 -0.30 (0.17) 1 1.88 (0.09) 0 6.59 (0.06) 1 0.11 (0.05) 0 111.8 (3.9) 1 0 MNK
IAI13 10.13 -1.07 (0.14) 0 1.25 (0.31) 0 -3.00 (0.00) 0 0.04 (0.01) 0 140.5 (3.5) 0 0 MNK
IAI15 9.01 -5.00 (0.00) 0 -1.37 (0.42) 0 -3.00 (0.00) 0 0.73 (0.33) 1 135.9 (18.3) 0 0 MNK
IAI19 5.25 -0.66 (0.08) 1 3.28 (0.83) 1 -3.00 (0.00) 0 3.51 (0.60) 1 132.4 (6.6) 0 0 MNK
IAI21 8.08 -5.00 (0.00) 0 -1.66 (0.57) 0 -2.23 (0.77) 0 0.06 (0.02) 0 124.5 (3.9) 0 0 MNK
IAI39 7.33 -4.23 (0.77) 0 2.38 (0.20) 0 -3.00 (0.00) 0 0.03 (0.01) 0 142.4 (8.4) 0 10 MK
IAI44 9.67 -4.23 (0.77) 0 1.83 (0.13) 0 0.57 (0.36) 1 0.43 (0.06) 1 134.2 (7.5) 0 1 MNK
IAI48 8.70 -0.43 (0.22) 1 0.83 (0.47) 0 1.21 (2.12) 1 0.07 (0.00) 0 152.9 (7.9) 0 0 MNK
IAI49 7.73 -0.18 (0.06) 1 3.94 (0.37) 1 -3.00 (0.00) 0 2.45 (0.41) 1 116.8 (3.5) 1 10 MK
IAI51 6.08 -2.86 (1.12) 0 3.41 (0.30) 1 -3.00 (0.00) 0 0.04 (0.00) 0 113.0 (2.4) 1 10 MK
IAI52 5.99 -3.04 (1.07) 0 3.07 (0.98) 1 -3.00 (0.00) 0 0.04 (0.00) 0 111.8 (1.8) 1 10 MK
IAI60 9.87 -2.90 (1.08) 0 2.05 (0.11) 0 4.65 (1.09) 1 1.03 (0.39) 1 100.9 (1.7) 1 1 MNK
IAI64 7.56 -4.33 (0.67) 0 2.33 (0.99) 0 -0.67 (1.39) 0 0.96 (0.37) 1 112.4 (8.5) 1 10 MK
IAI72 7.05 -0.98 (0.09) 1 3.88 (0.54) 1 6.58 (0.37) 1 0.04 (0.00) 0 120.2 (3.4) 0 10 MK
IAI73 6.48 -0.44 (0.09) 1 3.96 (0.43) 1 2.85 (0.23) 1 3.01 (0.46) 1 236.3 (7.0) 0 10 MK
IAI74 5.42 -5.00 (0.00) 0 3.34 (0.81) 1 -3.00 (0.00) 0 1.27 (0.27) 1 107.7 (36.8) 1 10 MK
ColF6c 7.49 -0.94 (0.31) 1 2.78 (0.56) 1 6.66 (0.13) 1 0.04 (0.01) 0 114.3 (5.4) 1 10 MK
ECOR64 6.27 -0.18 (0.11) 1 4.10 (0.33) 1 -3.00 (0.00) 0 0.03 (0.01) 0 123.8 (4.3) 0 10 MK
EC7372 6.92 -0.27 (0.12) 1 1.47 (0.31) 0 5.24 (0.53) 1 1.33 (0.39) 1 101.4 (3.0) 1 10 MK
ECOR58 6.17 -0.02 (0.07) 1 2.34 (0.47) 0 6.81 (0.17) 1 0.40 (0.11) 1 105.0 (6.2) 1 10 MK
Ben13f 5.49 -0.24 (0.09) 1 2.66 (0.34) 1 6.27 (0.35) 1 0.03 (0.01) 0 110.6 (3.4) 1 10 MK
536 5.97 0.01 (0.01) 1 3.43 (0.41) 1 6.59 (0.06) 1 2.57 (0.32) 1 114.3 (0.6) 1 9 MK
536 
 
rfe 7.72 -5.00 (0.00) 0 1.10 (0.18) 0 -3.00 (0.00) 0 0.25 (0.09) 0 156.3 (4.3) 0 NA NA
536 
 
PAI III 6.72 -0.17 (0.07) 1 2.15 (0.06) 0 6.58 (0.04) 1 2.09 (0.18) 1 125.3 (4.6) 0 NA NA
536 
 
HPI 5.83 -0.01 (0.08) 1 3.40 (0.06) 1 5.50 (0.97) 1 1.40 (0.21) 1 126.8 (1.5) 0 NA NA
Resistance 
to Serum 
(S.E.M)*
Resistance 
to 
Lysozyme 
(S.E.M)*
Resistance 
to  Bovine 
Bile 
(S.E.M)* 
Motility 
(S.E.M)* 
Table 1 Phenotypique characterization of E. coli  wild type and mutant strains.  
* Measured as described in Material and Method; S.E.M Standard Error of the Mean  
Generation 
time (min) 
(S.E.M)*
† Number of dead mice after 7 days post-intraperitoneal inoculation; MK: Mice Killer; MNK: Mice Non Killer; NA: Not available
‡ Binarization was based on a graphic representation (histogram) of the data from the wild type natural isolates, exept for growth rate where an above-or-
below-the-median criterion was used  
 
 Strain Origin† Type‡
Phylogenetic 
group serotype
K1 
antigen 
(neuC) sfa/foc iroN
aer 
(iucC) papC papG* hly cnf1 hra fyuA irp2 PAI I CFT073 PAI II J96 PAI III 536
HPI         
(PAI IV 536)
MG1655 Fs Lab A O16 - - - - - - - - - - - - - - -
OP50 ND Lab A0 ND - - - - - - - - - - - - - - -
F11 Ur UTI B2 O6:K15 - + + - + III + + + + + - + + +
F63 Ur UTI B2 O18:K1 + + + - + III + + + + + - + + +
RS218 CSF MNN B2 O18:K1 + + + - + III + + + + + - + + +
ED1A Fs C B2 O81 - - - + - - - - - - - - - - -
CFT073 Bl S B2 O6:K2 - + + + + II + - - + + + - + +
J96 Ur UTI B2 O4:K6 - + + - + I+III + + + + + - + + +
IAI1 Fs C B1 O8w -
- - - - - - - - - - - - - -
IAI2 Fs C B1 ONT -
- - - - - - - - - - - - - -
IAI4 Fs C A ONT -
- - - - - - - - - - - - - -
IAI12 Fs C A O148 -
- - - - - - - - - - - - - -
IAI13 Fs C A O1 -
- - - - - - - + - - - - - -
IAI15 Fs C A ONT -
- - - - - - - - + + - - - +
IAI19 Ur UTI A O? -
- - - - - - - - - - - - - -
IAI21 Ur UTI B1 O? -
- - - - - - - - - - - - - -
IAI39 Ur UTI D O7:K1 +
- - + + II - - - + + - - - +
IAI44 Ur UTI A O12 -
- - - - - - - - + + - - - +
IAI48 Bl S B2 O81 - - - + - - - - - - - - - - -
IAI49 Ur UTI B2 O8 - - + - - - - - - + + - - - +
IAI51 Ur UTI B2 O?:K1 + + + - - - - - - + + - - + +
IAI52 Ur UTI B2 O?:K1 + + + - - - - - - + + - - + +
IAI60 Bl S B2 O2:K1 + - + + + II - - - + + - - - +
IAI64 Ur UTI B2 O83 - + + - + III + + + + + - + + +
IAI72 Ur UTI B2 O2 - + + + + II + + + + + - + + +
IAI73 Bl S B2 O6 - + + - + III + + + + + - + + +
IAI74 Ur UTI B2 O2:K1 + + + - + III + + + + + - + + +
ColF6c Fs C B2 O2 - - - - + II + + + + + - + - +
ECOR64 Ur UTI B2 O75:K5 - + + - - - - - - + + - - + +
EC7372 Ur UTI B2 O25 - - - + + II + - - + + + - - +
ECOR58 Fs C B1 O112 - + + - - - - - - - - - - + -
Ben13f Fs C B2 O6 - + + - + III - - + + + - - + +
536 Ur UTI B2 O6:K15 - + + - + III + - + + + - + + +
(+) presence ; (-) absence; PAI: Pathogenicity Island; HPI: High Pathogenicity Island
Table 2: E. coli  strains
† Fs: Feces of healthy individual;  Bl: Blood of scepticemic patient; Ur: Urine of urinary tract infected patient; CSF: Cerebro Spinal Fluid of new born patient with meningitis
‡ The type of a given strain was determined by his origin, except for OP50 and MG1655, the two laboratory (Lab) strains. C: Commensal; UTI: Urinary Tract Infectious; 
MNN: Meningitis associated;  S: Scepticemia associated
* For papG, the presence of the three existing alleles is indicated by his number (I, II or III) 
 
  
 
Figure 1: Cox proportional hazards survival analysis of C. elegans fed on different E. coli natural 
isolates. Values on the x-axis represent virulence of the E. coli strains, measured as the relative effect on 
worm mortality rate when grown on the natural isolate compared to the reference food strain OP50.  
Horizontal bars represent 95%-confidence intervals for the effect of each strain; the vertical dashed line 
corresponds to no effect (=0 and thus e =1). Inspired by this representation, the boundary between the 
classes “slow killer” and “fast killer” were arbitrarily chosen to be between strains Ec7372 and IAI73. 
 
 
 
 
 
 
  
Figure 2. Projections of the 34 bacterial variables characterized in the 31 E. coli strains on the plane 
F1/F2 computed from the Factorial analyses of correspondence. The abreviations were as follows: A, 
B1, B2, and D, phylogenetic groups A, B1, B2 and D; O2, O6, O18, O81, Od, serotypes O2, O6, O18, 
O81, O divers types; Serum R, serum resistance; Bile R, bile resistance; Lysozyme R, 
lysozyme/lactoferrin resistance; MK, mouse killer; MNK, mouse non killer; FWK, fast worm killer; 
SWK, slow worm killer; the virulence factors are abreviated as in table S2. For clarity, irp and fuyA are 
projected on the same point that HPI and Commensal, Pathogen, MK, MNK, FWK and SWK are in 
bold types. 
 
 
 Figure 3. Cox proportional hazards survival analysis of C. elegans fed on different E. coli isolates with 
regard to different phenotypic and genetic variables. Values on the x-axis represent the effect of each 
trait when compared between the 2 classes for each variable (Table 1). Horizontal bars represent 95%-
confidence intervals for the effect of each covariate; the vertical dashed line corresponds to no effect 
(=0 and thus e =1). a) Presence of ExPEC pathogenicity islands PAI II and PAI III but not HPI (after 
adjustment for multiple comparisons) were associated with increased mortality of C. elegans. b) Of the 
5 observed phenotypes, only resistance to lysozyme/lactoferrin and to human serum significantly 
correlate with pathogenicity. c) On the average, strains that kill mice double the mortality of C. elegans. 
 
 
Figure 4. Cox proportional hazards survival analysis of C. elegans fed on different E. coli 536 mutant 
strains. Horizontal bars represent 95%-confidence intervals for the effect of each deletion compared to 
the ancestor strain; the vertical dashed line represents neutrality (=0 and thus e =1). rfe was the most 
attenuated strain (about 2.5 fold lower mortality), PAI III was attenuated about 1.5 fold; deletion of 
HPI had no significant effect on worm mortality.  
 
 
 
 
 Supplementary material 
 
Construction of E. coli 536 strain mutants. High Pathogenicity island (HPI) and rfe gene mutants of 
E. coli 536 strain were obtained using the PCR-based method of Datsenko and Wanner ((6)). A 
temperature-sensitive plasmid pKD46, which carries the bacteriophage  Red system (, , and exo 
genes) under the control of an arabinose-inducible promoter, was introduced by electroporation into the 
E. coli 536 strain. The chloramphenicol acetyltransferase (cat) gene carried by plasmid pKD3 (REF) 
was amplified by PCR with primers bearing extensions of 40 nucleotides (Eurogentec, Seraing, 
Belgium) homologous to the initial and final portions of the target region. Transformation by 
electroporation of E. coli 536 strain (expressing bacteriophage  Red functions) with the PCR product 
yielded deletion of the targeted chromosomal region fused to the cat gene. The cat gene was eliminated 
by using plasmid pCP20 expressing FLP recombinase (REF), which acts on the directly repeated FLP 
recognition target (FRT) sites flanking the resistance gene in plasmid pKD3.) Correct introduction and 
excision of the cat gene were controlled by PCR by using primers flanking the initial and final portions 
of the target region. All the primers used are shown in Table 2S. 
Table S2. Oligonucleotide primers 
 
Primer 
designation 
Primer sequence Réference 
rfe.P0 
rfe.P2 
rfe.FR1 
rfe.FR2 
HPI.P0 
HPI.P2 
HPI.FR1 
HPI.FR2 
5’GTGAATTTACTGACAGTGAGTACTGATCTCATCAGTATTTTGTGTAGGCTGGAGCTGCTTC-3’ 
5’-CATAGAGGAAGAATGCTAGCAAAAAGAGCACCAGCATGACCATATGAATATCCTCCTTAG-3’ 
5’-GCGCTGGCGATGTTAGGAA-3’ 
5’-GATGGTTGGTCGGCAGAAG-3’ 
5’-GCTGGCTATCCTGAAATACGGAACGCAGAACTAGCGCCGCTGTGTAGGCTGGAGCTGCTT-3’ 
5’-GTACGGTAACGACGGTCGAACAGGTTATCGACATAGACGGCATATGAATATCCTCCTTAG-3’ 
5’-TGAGTCATCAGGAGCGCAAT-3’ 
5’-AAGGAGAGAAAGGAACGAGAAA-3’ 
This study 
This study 
This study 
This study 
(19) 
 (19) 
(19) 
 
Oligonucleotide primers used for gene inactivation are designated by the suffixes P0 and P2; 
boldface characters in the primer sequences indicate the 20 nucleotides homologous to the cat gene 
sequence. The oligonucleotide primers used to control correct introduction and excision of the cat gene 
are designated by the suffixes FR1and FR2 and flank the target gene or region. 
 
Genetic characterization of the E. coli natural isolates (partie pour Olivier) 
 
 
 
 Survival curves of C. elegans fed with different strains of E. coli 
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